Who wants to start a class action going..., page-58

First 58 Last

Share
Profile

Follow
ozexplorer

14,963 Posts.

56

20/04/18

12:50

Post #: 32584825
Share

Originally posted by Michael27 ↑

Yes It’s about time ASIC took a good look at the Directors on the ASX and their conduct specifically in regard to due diligence, disclosure, performance rights based issues etc.

I emailed Paul Jurman in regard to the initial due diligence (taking six weeks instead of the allocated 8. Who conducted the due diligence, who the consultant was, how much were they paid and a copy of the report.

Answer: not available to the public. ?????

The initial decision to invest, pour enormous amounts of share holders money from monthly capital raisings, one of which was an amount for a benchmark for the next tranche being four prototypes of the scanning equipment for analytics. There were only two produced. There are many groups involved in this orchestrated debacle.

Past and present.

What the hell is going on. Lgs is uncontactable and there seems to be no alternative to realist NXR with an alternative investment.

Disclosure: I do hold both WBT and NXR. No contact or update from WBT.

What the hell is going on?

Too much money spent on marketing, brokers reports, media coverage, directors fees for both companies, (unwarranted performance rights for NXR directors cashed in at .10 x 1,000,000 - six months before they ran away), costs of capital raisings to Cicero.

And how much was spent on the technology???

The above are my conclusions only and cannot be relied upon as fact.

Expand

As WBT is a private company its time you wrote a letter to the directors of WBT what is going on an what have they done over the last 2 and half years..... send it to them via registered mail or deliver it personally when they have their meetings...... Also record all emails you send to them......

I think LGS is trying to sort everything out the best he can....but he has inherited a big Mess to sort out.....

Give the former CEO a Big gee up as the faults.....lie in her time line......of leadership...an info distribution to certain period.....

NXR Price at posting: 2.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

There are more pages in this discussion • 44 more messages in this thread...

First 58 Last

Add NXR (ASX) to my watchlist

Who wants to start a class action going..., page-58

Top Stories

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chimeric clocks $4.17M R&D tax rebate from Canberra

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals